These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7324227)

  • 41. [Oral vasodilators in chronic cardiac insufficiency].
    Sánchez Domínguez J; González Villa J
    Rev Clin Esp; 1979 Jun; 153(5):403-8. PubMed ID: 493602
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of heart insufficiency with vasodilators. Principles and practical aspects].
    Bertel O
    Fortschr Med; 1983 Aug; 101(31-32):1437-9. PubMed ID: 6618407
    [No Abstract]   [Full Text] [Related]  

  • 43. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of cardiac insufficiency in acute myocardial infarction with vasodilator agents. Physiopathological bases for their use].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1980; 33(2):173-84. PubMed ID: 7403621
    [No Abstract]   [Full Text] [Related]  

  • 46. [Vasodilators and cardiac insufficiency].
    Domingo E; Lupón Rosés J
    Med Clin (Barc); 1988 Jan; 90(3):110-1. PubMed ID: 3280888
    [No Abstract]   [Full Text] [Related]  

  • 47. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An overview of inotropic agents.
    Vroom MB
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vasodilation therapy of cardiac insufficiency in ischemic heart disease].
    Stanĕk V; Málek I; Pavlovic J; Widimský J
    Cas Lek Cesk; 1979 Nov; 118(48):1486-93. PubMed ID: 535023
    [No Abstract]   [Full Text] [Related]  

  • 52. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Concept for therapy of heart failure in heart surgery].
    Zerkowski HR; Günnicker M; Marggraf G; Reidemeister JC
    Z Kardiol; 1994; 83 Suppl 2():55-61. PubMed ID: 8091825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vasodilator agents in the therapy of cardiac insufficiency].
    ZFA (Stuttgart); 1980 Mar; 56(8):565-6. PubMed ID: 7415501
    [No Abstract]   [Full Text] [Related]  

  • 56. [Changes in renal hemodynamics and renal function in patients with cardiac insufficiency treated with vasodilators].
    Leshchinskiĭ LA; Pimenov LT; Trusov VV
    Ter Arkh; 1981; 53(8):80-4. PubMed ID: 7292349
    [No Abstract]   [Full Text] [Related]  

  • 57. Vasodilator treatment of heart failure.
    Taylor SH
    Practitioner; 1981 Oct; 225(1360):1419-29. PubMed ID: 7329932
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of peripheral vasodilator agents in chronic cardiac insufficiency].
    Zhukova AA; Eliseev OM
    Vopr Revm; 1982; (1):48-55. PubMed ID: 7046243
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacology of vasodilator drugs; recent developments].
    van Zwieten PA; van Meel JC; de Jonge A; Kalkman HO; Timmermans PB
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():78-86. PubMed ID: 7187165
    [No Abstract]   [Full Text] [Related]  

  • 60. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance.
    Cohn JN
    Circulation; 1973 Jul; 48(1):5-8. PubMed ID: 4781249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.